With 115.87 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.12 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $7.4899 whereas the lowest price it dropped to was $2.71. The 52-week range on APM shows that it touched its highest point at $17.49 and its lowest point at $0.46 during that stretch. It currently has a 1-year price target of $80.00. Beta for the stock currently stands at 0.91.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of APM was up-trending over the past week, with a rise of 281.68%, but this was up by 330.77% over a month. Three-month performance surged to 67.66% while six-month performance fell -31.20%. The stock gained 9.80% in the past year, while it has gained 14.35% so far this year.
Float and Shares Shorts:
At present, 3.67 million APM shares are outstanding with a float of 2.17 million shares on hand for trading. On 2024-11-29, short shares totaled 18927.0, which was 34.0 higher than short shares on 1730332800. In addition to Mr. Chung Yuen Huen as the firm’s Founder, CEO & Non-Executive Director, Mr. Kwok Kuen Wong serves as its Head of Finance.
Institutional Ownership:
Through their ownership of 0.01459 of APM’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
Analysts have provided yearly estimates in a range of -$0.7 being high and -$0.7 being low. For APM, this leads to a yearly average estimate of -$0.7. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
